MedPath

湖南尚众合生物医药有限公司

Ownership
-
Established
2022-05-25
Employees
-
Market Cap
-
Website
http://www.shangzhonghe.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Aspirin Vitamin C Effervescent Tablets

Product Name
阿司匹林维生素C泡腾片
Approval Number
国药准字H20254381
Approval Date
May 27, 2025
NMPA

Indobufen Tablets

Product Name
吲哚布芬片
Approval Number
国药准字H20258088
Approval Date
May 23, 2025
NMPA

Indobufen Tablets

Product Name
吲哚布芬片
Approval Number
国药准字H20243224
Approval Date
Feb 23, 2024
NMPA

Lincomycin Hydrochloride Injection

Product Name
盐酸林可霉素注射液
Approval Number
国药准字H43021384
Approval Date
Nov 15, 2022
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.